China Biopharmaceutical (01177) subsidiary enters into strategic cooperation with STADA for biosimilars.

Zhitong Finance APP News: China Biopharmaceutical (01177) announced that its subsidiary Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (Chia Tai Tianqing) and STADA Arzneimittel AG (STADA) have entered into a strategic collaboration on biosimilars, and the two parties will work together to enhance patient access to biosimilars in multiple regions worldwide.